Vaccinations for flu, tetanus and other common vaccines are increasingly taking place in non-medical settings such as supermarkets and drug stores. This added responsibility for pharmacists increases the risk of needlestick injuries (NSIs), puncture wounds often suffered while preparing or after use of a needle. NSIs can transmit bloodborne pathogens, including hepatitis C and HIV, from an infected patient to the person administering the vaccine.
A new report to be published in the November issue of Infection Control and Hospital Epidemiology found 33 NSIs occurred at 31 difference pharmacy locations of a nationwide retail pharmacy chain over an 11-year period. Over the same period of time, the chain administered more than 2 million vaccinations. Researchers calculated that the annual incidence of NSIs ranged from 0 to 3.62 per 100,000 vaccinations and 0 to 5.65 NSIs per 1,000 immunizing pharmacists. This incidence rate may represent an underestimation of NSIs since past studies have found that NSIs are often underreported by healthcare workers.
Most often NSIs were reported to have occurred after use and before disposal of the needle (58 percent of incidents) and during peak influenza vaccination months (79 percent).
Pharmacists have become an emerging occupational group at risk of needlestick injuries, says Marie de Perio, MD, medical officer in the National Institute for Occupational Safety and Health at the Centers for Disease Control and Prevention (CDC). While the incidence of needlestick injuries among employees at this retail pharmacy chain appears to be lower than that found in hospital settings, most of the injuries that did occur were likely preventable by following safe work practices.
Researchers recommend that the company continue to follow existing CDC guidelines to improve its NSI prevention program and add additional information to track the circumstances of the injury to help determine contributing factors.Â
Reference: de Perio MA. Needlestick Injuries among Employees at a Nationwide Retail Pharmacy Chain, 20002011. Infection Control and Hospital Epidemiology 33:11. November 2012.
Â
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.